MANNKIND CORP Other Deferred Credits, Current
MANNKIND CORP (MNKD) had Other Deferred Credits, Current of $26.88 million as of 2016-06-30, per its 10-Q/A filed 2016-08-10.
Discontinued › Notes › ASU 2014-09 Transition
us-gaap:OtherDeferredCreditsCurrent · last filed 2016-08-10
- 2016-06-30: Other Deferred Credits, Current $26.88M; Other Deferred Credits, Current as first filed $17.68M.
- 2016-03-31: Other Deferred Credits, Current $17.68M.
- 2015-12-31: Other Deferred Credits, Current $17.50M.
- 2015-09-30: Other Deferred Credits, Current $17.47M.
| Period end | Other Deferred Credits, Current | Other Deferred Credits, Current as first filed |
|---|---|---|
| 2016-06-30 | $26.88M 10-Q/A · filed 2016-08-10 | $17.68M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $17.68M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $17.50M 10-Q/A · filed 2016-08-10 | |
| 2015-09-30 | $17.47M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $13.40M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $7.05M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $436.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |